« Previous | Next » | All Messages |  MGEN Message Board Home | recommend post |  Ignore Poster

MGEN News Med Gen's Painenz(R) Receives National Health & Wellness Club Seal of Approval

BOCA RATON, Fla.--(BUSINESS WIRE)--Med Gen Inc. (OTCBB:MGEN), manufacturer of nationally branded OTC healthier life products, announced today that it has received the National Health & Wellness Member Tested & Recommended Seal of Approval. The test, which was announced in an earlier News Release by the company, got high marks for performance/effectiveness, ease of use, lifestyle impact and rating against similar products.

Painenz® is designed as an instant pain relief formula for the millions of Arthritis sufferers world-wide. Mr. Kravitz, Med Gen’s 74 year old Chairman, told analysts that his daily use of Painenz® allows him to work 12-14 hour days without severe pain from his stenosis and arthritis. “It’s one of the best products in our line," he further stated. Painenz® is available now on the www.medgen.com website at a 20% discount by filling out the company questionnaire.

Painenz® is also undergoing tests in Gardening-How-To® and PGA TOUR® magazines.

About Med Gen Inc.

Med Gen Inc., in business since 1996, manufactures and markets specialty products using its proprietary delivery system, Spray’s the Way (“STW”). It is best known for producing the world’s first patented liquid spray snoring relief formula, Snorenz®. Since its existence, Med Gen has continued to develop its STW technology, introducing Good Nights Sleep® and the Un-Diet™ system into its family of brands. While STW technology is mainly used, the company also produces other products that deal with common health issues using other delivery systems. The company markets its products to distributors, major chain and drug stores, direct sales via the company web site and direct to consumer television, radio and print advertising. The company also distributes its brands internationally under various private labels or existing names.

Med Gen Inc. is a fully reporting company whose stock trades on the OTCBB under the symbol “MGEN”. For information contact Investor Relations 561-750-1100 or www.medgen.com.

This Press Release contains or incorporates by reference “forward looking" statements including certain information with respect to plans and strategies of Med Gen Inc. For this purpose, any statements contained herein or incorporated herein by references that are not statements of historical fact may be deemed forward looking statements. Without limiting the foregoing, the words “believes”, “suggests”, “anticipates”, “plans”, “expects”, and similar expressions are intended to identify forward looking statements. There are a number of events or actual results of Med Gen operations that could differ materially from those indicated by such forward looking statements.